641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster III

Genomic profiling in CLL patients after BTK inhibitor progression identifies enrichment of mutations in MAPK pathway and epigenetic regulators

Harnessing repressive LEF1 ß catenin complexes to overcome drug resistance in chronic lymphocytic leukemia

Peptide based antagonists for targeting CXCR4 in ibrutinib resistant chronic lymphocytic leukemia

Longitudinal immune dynamics associated with chronic lymphocytic leukemia development in mice with 13q14 deletion and modulation by early BTK inhibition

Role of the immune microenvironment in the clonal evolution of chronic lymphocytic leukemia